RAB9A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.552000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.927170E-01
Normal-vs-Stage2
3.126400E-01
Normal-vs-Stage3
2.241400E-01
Normal-vs-Stage4
7.052000E-01
Stage1-vs-Stage2
4.837800E-01
Stage1-vs-Stage3
8.730800E-01
Stage1-vs-Stage4
6.012200E-01
Stage2-vs-Stage3
4.370600E-01
Stage2-vs-Stage4
7.592800E-01
Stage3-vs-Stage4
6.031800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.268200E-01
Normal-vs-AfricanAmerican
6.227400E-01
Normal-vs-Asian
5.977400E-01
Caucasian-vs-AfricanAmerican
3.671000E-01
Caucasian-vs-Asian
4.166000E-01
AfricanAmerican-vs-Asian
8.557400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.621390E-01
Normal-vs-Female
4.144200E-01
Male-vs-Female
1.990390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.712200E-01
Normal-vs-Age(41-60Yrs)
6.964200E-01
Normal-vs-Age(61-80Yrs)
1.335760E-01
Normal-vs-Age(81-100Yrs)
8.744200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.115410E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.839600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.275600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.389780E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.390400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.132000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.410200E-01
Normal-vs-Daily Drinker
9.239600E-02
Normal-vs-Weekly Drinker
1.071450E-01
Normal-vs-Occasional Drinker
6.104600E-01
Normal-vs-Social Drinker
9.947800E-02
Non Drinker-vs-Daily Drinker
2.332000E-01
Non Drinker-vs-Weekly Drinker
3.397200E-01
Non Drinker-vs-Occasional Drinker
4.292600E-01
Non Drinker-vs-Social Drinker
7.493400E-01
Daily Drinker-vs-Weekly Drinker
9.402200E-01
Daily Drinker-vs-Occasional Drinker
6.828000E-02
Daily Drinker-vs-Social Drinker
3.415600E-01
Weekly Drinker-vs-Occasional Drinker
1.246800E-01
Weekly Drinker-vs-Social Drinker
4.099000E-01
Occasional Drinker-vs-Social Drinker
2.796800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.509600E-01
Normal-vs-Grade 2
8.342000E-02
Normal-vs-Grade 3
5.545200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.320610E-03
Grade 1-vs-Grade 3
1.655810E-03
Grade 1-vs-Grade 4
4.509600E-01
Grade 2-vs-Grade 3
8.018800E-01
Grade 2-vs-Grade 4
8.342000E-02
Grade 3-vs-Grade 4
5.545200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.300580E-01
Normal-vs-NonDiabetic
2.655000E-01
Diabetic-vs-NonDiabetic
4.652000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.837800E-01
Normal-vs-NoPancreatitis
2.181200E-01
Pancreatitis-vs-NoPancreatitis
7.553700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.207600E-02
Normal-vs-N1
3.554800E-01
N0-vs-N1
5.575600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.696800E-01
Normal-vs-TP53-NonMutant
1.286830E-01
TP53-Mutant-vs-TP53-NonMutant
3.357600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
